JP2017513809A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513809A5
JP2017513809A5 JP2016552499A JP2016552499A JP2017513809A5 JP 2017513809 A5 JP2017513809 A5 JP 2017513809A5 JP 2016552499 A JP2016552499 A JP 2016552499A JP 2016552499 A JP2016552499 A JP 2016552499A JP 2017513809 A5 JP2017513809 A5 JP 2017513809A5
Authority
JP
Japan
Prior art keywords
steady state
dose
pharmaceutical composition
testosterone
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016552499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513809A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/016505 external-priority patent/WO2015127012A1/en
Publication of JP2017513809A publication Critical patent/JP2017513809A/ja
Publication of JP2017513809A5 publication Critical patent/JP2017513809A5/ja
Withdrawn legal-status Critical Current

Links

JP2016552499A 2014-02-19 2015-02-19 テストステロン組成物の針に補助されるジェット注射投与 Withdrawn JP2017513809A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461941875P 2014-02-19 2014-02-19
US61/941,875 2014-02-19
PCT/US2015/016505 WO2015127012A1 (en) 2014-02-19 2015-02-19 Needle assisted jet injection administration of testosterone compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019237675A Division JP2020073545A (ja) 2014-02-19 2019-12-27 テストステロン組成物の針に補助されるジェット注射投与

Publications (2)

Publication Number Publication Date
JP2017513809A JP2017513809A (ja) 2017-06-01
JP2017513809A5 true JP2017513809A5 (enExample) 2018-03-29

Family

ID=53878936

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016552499A Withdrawn JP2017513809A (ja) 2014-02-19 2015-02-19 テストステロン組成物の針に補助されるジェット注射投与
JP2019237675A Pending JP2020073545A (ja) 2014-02-19 2019-12-27 テストステロン組成物の針に補助されるジェット注射投与
JP2023007294A Pending JP2023052550A (ja) 2014-02-19 2023-01-20 テストステロン組成物の針に補助されるジェット注射投与
JP2025015053A Pending JP2025072449A (ja) 2014-02-19 2025-01-31 テストステロン組成物の針に補助されるジェット注射投与

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019237675A Pending JP2020073545A (ja) 2014-02-19 2019-12-27 テストステロン組成物の針に補助されるジェット注射投与
JP2023007294A Pending JP2023052550A (ja) 2014-02-19 2023-01-20 テストステロン組成物の針に補助されるジェット注射投与
JP2025015053A Pending JP2025072449A (ja) 2014-02-19 2025-01-31 テストステロン組成物の針に補助されるジェット注射投与

Country Status (5)

Country Link
US (5) US10238662B2 (enExample)
EP (2) EP3107547A4 (enExample)
JP (4) JP2017513809A (enExample)
CA (1) CA2939791C (enExample)
WO (1) WO2015127012A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3107547A4 (en) 2014-02-19 2017-11-15 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
US11116911B2 (en) * 2016-04-11 2021-09-14 Biogen Ma, Inc. Injector lockout prevention device
GB2583231B (en) * 2017-11-14 2023-07-19 Cook Biotech Inc Sterilized tissue products and related methods
JP2021502814A (ja) 2017-11-14 2021-02-04 クック・バイオテック・インコーポレイテッドCook Biotech Incorporated 保存組織製品および関連する方法
PT3801694T (pt) 2018-06-08 2025-10-30 Antares Pharma Inc Injetor de auto-inserção
CA3104910C (en) 2018-07-24 2023-08-29 Antares Pharma, Inc. Injector with safety cap
CN111110959B (zh) * 2020-02-06 2021-08-13 周冬兵 一种医疗领域使用的注射器
AU2021309966A1 (en) 2020-07-15 2023-02-09 Biogen Ma Inc. Medical system including two access ports
ES3017862T3 (en) * 2020-10-16 2025-05-13 Shandong Wego Prefills Pharmaceutical Packaging Co Ltd Automatic syringe
EP4173656A1 (en) 2021-10-27 2023-05-03 medmix Switzerland AG Needle guard, drug delivery device and method for manufacturing
US12605537B2 (en) 2022-02-15 2026-04-21 Biogen Ma Inc. Implantable medical device for use with or having recording electrode
CN119866230A (zh) * 2022-09-13 2025-04-22 株式会社大赛璐 注入器和使用该注入器注入溶液的方法
WO2026013548A1 (en) * 2024-07-08 2026-01-15 Auckland Uniservices Limited Jet injector

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428528B2 (en) 1998-08-11 2002-08-06 Antares Pharma, Inc. Needle assisted jet injector
US6391003B1 (en) 1999-10-25 2002-05-21 Antares Pharma, Inc. Locking mechanism for a jet injector
ATE409057T1 (de) 2002-02-11 2008-10-15 Antares Pharma Inc Intradermales injektionsgerät
US7449012B2 (en) 2004-08-06 2008-11-11 Meridian Medical Technologies, Inc. Automatic injector
WO2006079064A1 (en) 2005-01-24 2006-07-27 Antares Pharma, Inc. Prefilled needle assisted jet injector
US20100144687A1 (en) * 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor
AU2010226442A1 (en) 2009-03-20 2011-10-13 Antares Pharma, Inc. Hazardous agent injection system
MX395212B (es) * 2011-05-15 2025-03-21 Acerus Biopharma Inc Geles nasales de liberación controlada de testosterona, métodos y sistemas aplicadores multidosis pre cargados para administración pernasal.
EP2833944A4 (en) 2012-04-06 2016-05-25 Antares Pharma Inc ADMINISTRATION OF TESTOSTERONE COMPOSITIONS BY NEEDLE-SUPPORTED NOZZLE INJECTION
US20140171918A1 (en) * 2012-12-14 2014-06-19 Bioject, Inc. Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
WO2015054213A1 (en) * 2013-10-07 2015-04-16 Wotton Paul K Hematocrit modulation through needle assisted jet injection of testosterone
EP3107547A4 (en) * 2014-02-19 2017-11-15 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions

Similar Documents

Publication Publication Date Title
JP2017503820A5 (enExample)
RU2017134443A (ru) Способ лечения с применением традипитанта
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2016528302A5 (enExample)
JP2018507243A5 (enExample)
JP2016510326A5 (enExample)
PH12019500154A1 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
JP2017503014A5 (enExample)
JP2016516773A5 (enExample)
JP2019532047A5 (enExample)
JP2013537915A5 (enExample)
JP2017533220A5 (enExample)
JP2012502103A5 (enExample)
JP2017503846A5 (enExample)
JP2015522603A5 (enExample)
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
JP2018526460A5 (enExample)
FI3352735T3 (fi) Pitkitetysti vapauttavia olantsapiiniformulaatioita
HK1255584A1 (zh) 使用阿坎酸及d-环丝胺酸的联合疗法
JP2019507786A5 (enExample)
JP2016512247A5 (enExample)
JP2016505050A5 (enExample)
JP2019511506A5 (enExample)
WO2016015798A9 (en) Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
WO2016122288A3 (ko) 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제